Wei-Jun Fan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Wei-Jun Fan

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

European Radiology Experimental|June 16, 2026

TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysisRong Ding, Xiao-Yang Xu, Rui-Bao Liu, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2026

Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II TrialHai-Dong Zhu, Wei-Jun Fan, Chang Zhao, et al.

Hepatology International|October 21, 2023

Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendationsMing Zhao, Zhi Guo, Ying-Hua Zou, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

European Radiology Experimental|June 16, 2026

TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysisRong Ding, Xiao-Yang Xu, Rui-Bao Liu, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2026

Hepatology International|October 21, 2023

Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendationsMing Zhao, Zhi Guo, Ying-Hua Zou, et al.

Pageof 6